Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 24447565)

1.

[Research advance on c-myc in aggressive B cell lymphomas].

Zhou J, Ma J.

Zhonghua Bing Li Xue Za Zhi. 2013 Nov;42(11):786-8. Review. Chinese. No abstract available.

PMID:
24447565
2.

Epigenetics, c-Myc and aggressive B-cell lymphomas.

Zhang Y, Zhao X, Tao J.

Oncotarget. 2012 Nov;3(11):1264-5. No abstract available.

3.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

4.

Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.

Martín-Subero JI, Odero MD, Hernandez R, Cigudosa JC, Agirre X, Saez B, Sanz-García E, Ardanaz MT, Novo FJ, Gascoyne RD, Calasanz MJ, Siebert R.

Genes Chromosomes Cancer. 2005 Aug;43(4):414-23.

PMID:
15852472
5.

[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].

Luo DL, Liu YH, Zhang F, Xu FP, Yan LX, Chen J, Xu J, Luo XL, Zhuang HG.

Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8. Chinese.

PMID:
24314242
6.

MYC and aggressive B-cell lymphomas.

Slack GW, Gascoyne RD.

Adv Anat Pathol. 2011 May;18(3):219-28. doi: 10.1097/PAP.0b013e3182169948. Review.

PMID:
21490439
7.

Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Xu X, Zhang L, Wang Y, Zhang Q, Zhang L, Sun B, Zhang Y.

Int J Clin Exp Pathol. 2013;6(4):788-94. Epub 2013 Mar 15. Review.

8.

Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.

Tapia G, Lopez R, Muñoz-Mármol AM, Mate JL, Sanz C, Marginet R, Navarro JT, Ribera JM, Ariza A.

Histopathology. 2011 Oct;59(4):672-8. doi: 10.1111/j.1365-2559.2011.03978.x.

PMID:
22014048
9.

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.

Rodig SJ, Kutok JL, Paterson JC, Nitta H, Zhang W, Chapuy B, Tumwine LK, Montes-Moreno S, Agostinelli C, Johnson NA, Ben-Neriah S, Farinha P, Shipp MA, Piris MA, Grogan TM, Pileri SA, Gascoyne RD, Marafioti T.

Haematologica. 2010 Dec;95(12):2056-62. doi: 10.3324/haematol.2010.025767. Epub 2010 Sep 7.

10.

Gene regulation: fine-tuned amplification in cells.

Dang CV.

Nature. 2014 Jul 24;511(7510):417-8. doi: 10.1038/nature13518. Epub 2014 Jul 9. No abstract available.

PMID:
25043013
11.

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.

Ott G, Rosenwald A, Campo E.

Blood. 2013 Dec 5;122(24):3884-91. doi: 10.1182/blood-2013-05-498329. Epub 2013 Sep 5. Review.

12.

Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.

Nakagawa M, Tsuzuki S, Honma K, Taguchi O, Seto M.

Haematologica. 2011 Sep;96(9):1318-26. doi: 10.3324/haematol.2011.041053. Epub 2011 May 23.

13.

Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.

Ruzinova MB, Caron T, Rodig SJ.

Am J Surg Pathol. 2010 Jun;34(6):882-91. doi: 10.1097/PAS.0b013e3181db83af.

PMID:
20442643
14.

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.

Gualco G, Weiss LM, Barber GN, Bacchi CE.

Hum Pathol. 2010 Sep;41(9):1238-44. doi: 10.1016/j.humpath.2010.01.015. Epub 2010 Apr 10.

PMID:
20382409
15.

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.

Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.

PMID:
23348205
16.

Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?

Mationg-Kalaw E, Tan LH, Tay K, Lim ST, Tang T, Lee YY, Tan SY.

Histopathology. 2012 Dec;61(6):1214-8. doi: 10.1111/j.1365-2559.2012.04351.x. Epub 2012 Nov 21.

PMID:
23171357
18.

Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).

da Cunha Santos G, Ko HM, Saieg MA, Boerner SL, Lai SW, Bailey D, Geddie WR.

Cancer Cytopathol. 2011 Aug 25;119(4):254-62. doi: 10.1002/cncy.20156. Epub 2011 May 10.

PMID:
21560251
19.

Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.

Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC 3rd, Janz S.

Cancer Res. 2005 Feb 15;65(4):1306-15.

20.

Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.

Gostissa M, Yan CT, Bianco JM, Cogné M, Pinaud E, Alt FW.

Nature. 2009 Dec 10;462(7274):803-7. doi: 10.1038/nature08633.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk